Ukraine war: Injured soldier treated in Kent
Dmytro was a project manager in Kyiv before the war, but signed up to fight for his homeland on the first day of Putin's full-scale invasion of Ukraine.He was serving on the front line in the Donetsk region when his unit came under attack last July.He took shelter with a number of men and as shells rained down on them, two hit his hideout.Dmytro was the only one, from the shelter, who survived.
He initially thought he would recover quickly.As he lay in a hospital bed, he checked his hands and his legs were still there. He remembered thinking: "It's all right. I'll be good in a hurry and continue fighting."But he did not realise the extent of the injuries.His knees and right hand were badly damaged and he had also suffered severe nerve damage. He underwent 23 operations and had to learn how to walk again.
Dmytro's wife, Maryna, spent hours on paperwork and months waiting for permission to bring her husband to the UK. She said: "When the war stops, we're happy to be together in our country."For now, she said, she felt safer in the UK.
Dmytro now walks his eight-year-old daughter Diana to school every morning. He said walking 500 metres on crutches to get her to the school gates is excellent physiotherapy for him.Diana, meanwhile, is happy her dad is living with them. "Instead of just going on phone calls," she said, "you can talk to him and hug him when you want to."
Dmytro said he hoped he would soon walk without crutches. He also said he has "an obligation" when he is well enough to return home to help with the war effort.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
12 minutes ago
- Telegraph
Britain must stop subsidising pensioners to save the NHS
The Government recently produced a paper on the NHS entitled 'Fit for the Future – The 10 Year Health Plan for England'. It included many radical ideas and didn't pull its punches in regard to the need for reform. It said: 'The choice is stark: reform or die'. And, if nothing is done, it said, the NHS could become 'a poor service for poor people'. Despite its radical tone and many good ideas, this report did not go far enough. In particular, it accepted the continuation of the current system of funding whereby just about the whole cost of the Service is borne by the taxpayer. In a report published last week by Policy Exchange entitled 'The NHS – a Suitable Case for Treatment?', I and two co-authors went much further and called for an end to the system of predominantly taxpayer funding which has been the model since the NHS was founded in 1948. In the mid-1950s the government spent about 3pc of its GDP on healthcare. Today the figure is 9pc (excluding the private sector), amounting to almost a fifth of all government spending. If nothing is done, by 2070 we could end up spending more than a fifth of our GDP on the NHS. This is unacceptable. If we allowed this to happen, other sorts of public spending would have to be squeezed and/or taxes would have to be raised to eye-watering levels. This would have a devastating effect on incentives and therefore a materially depressing effect on the economy. The funding system is the first of the NHS's major problems. The second is inadequate quality. Many British people think that the NHS delivers a first-class service. Yet, it is clear that the NHS offers neither the best nor the worst healthcare in the world. Admittedly, at its best, it is superb, but the standard is hit and miss, and at its worst, it is pretty bad. Among a group of countries of comparable economic development (Australia, France, Germany, the Netherlands, Singapore, Switzerland and the US), on both life expectancy and healthy life expectancy the UK comes in second to last. Only the US scores worse. On preventable and treatable mortality, the UK again comes in second to last, ahead of only the US. On the proportion of patients waiting over a year to see a specialist, the UK is the highest in the group. We also perform badly on the ease of securing an appointment with a GP and access to GPs out of hours. What is to be done? Whenever someone criticises the NHS and suggests that we need to move to a different model, a chorus of voices loudly proclaims that we must not become like America. Indeed not. The US health system pulls off a remarkable double whammy. Although some of the best healthcare in the world is to be found in the United States, average health outcomes for the population as a whole are simply dire. Meanwhile, the system is about the most expensive in the world. However bad the NHS may seem, it is infinitely preferable to the American system. Under no circumstances should we consider copying the US. But we don't have to. There are many countries in the world which operate a different system for funding healthcare and enjoy better average health outcomes than the UK. The essence of their approach is to combine charging and co-payments with a system of social insurance. That is to say, compulsory purchasing of medical insurance, covering everyone in the population, with concessionary rates or even full reimbursement available for poor people. The state remains involved as both a partial funder, co-ordinator and regulator of the system. But governments spend much less on healthcare in these countries than we do, and thereby place a much smaller burden on their taxpayers. Countries that run such a system include Australia, Canada, France, Germany, the Netherlands, Singapore and Switzerland. The most outstandingly successful of these is Singapore. It spends only about 5pc of its GDP on healthcare and of that, not much more than a half comes from government. Meanwhile, Singapore achieves just about the best health outcomes in our comparator group. Yet Singapore is a very special case, with a particular political and social model. For an example that would serve the UK well, we should probably look closer to home. The obvious place to look is the Netherlands, not least because it underwent a radical reform of its health system in 2006. It delivers high standards of healthcare yet the government spends only 1pc of GDP on health. Some people will argue that we already have a system of insurance to pay for healthcare, namely National Insurance. Despite its name, however, this is not really a system of insurance. It is rather another form of tax. The amount of money the state pays for healthcare is not restricted by the amount of National Insurance contributions coming into the Treasury. Moreover, unlike pensions, where eligibility is connected with National Insurance contributions, a person's ability to access the NHS is not circumscribed by their NI contribution record. Moving from a system of funding through taxation to one based largely on social insurance is going to be a tough ask. It cannot be completed overnight. The place to start a programme to reform the financing of the NHS is with the introduction of a small charge for GP appointments and an end to the automatic entitlement to free prescriptions for pensioners, regardless of their financial circumstances. Doubtless many people will say that these proposals destroy the essence of the NHS as it was established in 1948. But the provision of healthcare in this country cannot be treated as a sort of museum exhibit. We can adhere to the spirit of the NHS in creating a system that delivers excellent healthcare for all within a funding framework that is right for the 21 st century.
The Independent
42 minutes ago
- The Independent
Groundbreaking cancer trial to recruit patients within the NHS
A new immunotherapy drug trial for glioblastoma, the deadliest form of brain cancer, is now recruiting patients in the NHS. The trial follows a previous study where patient Ben Trotman's tumour vanished, and he has shown no signs of the disease for over two years, a rare outcome for glioblastoma. The NHS study will enrol 16 patients over 18 months, who will receive the immunotherapy drug ipilimumab before standard treatment. The trial was established in memory of Baroness Margaret McDonagh, who died from the disease, and was funded by over £1 million raised by her sister, Dame Siobhain McDonagh MP. Led by Consultant Medical Oncologist Dr Paul Mulholland, the trial aims to build on previous findings and offers significant hope for patients with this aggressive cancer. Dad's aggressive brain cancer vanishes after taking new drug
Scottish Sun
an hour ago
- Scottish Sun
I've lost 25% of my weight on Mounjaro – here's 4 foods I avoided on fat jabs & the popular pick that made me feel sick
Plus, which foods gave her burps that smell like rotten eggs FOOD FOR THOUGHT I've lost 25% of my weight on Mounjaro – here's 4 foods I avoided on fat jabs & the popular pick that made me feel sick Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A WOMAN who's shed nearly 25% of her bodyweight thanks to Mounjaro has revealed which foods she steered clear of. TikToker Tami kickstarted her weight loss journey with the popular fat jab almost a year ago and within the last 50 weeks she's managed to drop a staggering 1/4 of her starting weight. Sign up for Scottish Sun newsletter Sign up 3 Tami kickstarted her weight loss journey with the popular fat jab almost a year ago Credit: tiktok/@cartcrushuk 3 She has since managed to shed almost 25% of her body weight Credit: tiktok/@cartcrushuk 3 Mounjaro is typically used to treat type 2 diabetes Credit: Getty Like many, Tami wasn't ''too clued up'' on what to do and which foods to consume. However, having been on Mounjaro for close to 12 months now, Tami has learnt what works for her, regularly sharing tips and tricks to others on the same journey. Mounjaro is regarded by some as the King Kong of weight loss jabs. Sun GP Dr Zoe Williams acknowledged that Mounjaro, which could soon be rolled out on the NHS, can save the lives of people with 'life-threatening levels of obesity.' But despite this, the NHS warned: 'Never take an anti-obesity medicine if it has not been prescribed to you. "These types of medicines may not be safe for you and can cause serious side effects.' About half a million Brits use weight loss drugs - and the number is expected to double in the next year. Mounjaro works by suppressing your appetite, making people feel fuller for longer. The injections are licensed for patients with type 2 diabetes and to assist those who are clinically obese (with a Body Mass Index of 30 or over). One jab is administered each week but the duration is dependent on someone's weight. I went on fat jabs but the hair loss was unbelievable so I quit - I'd rather be chubby with hair than skinny and bald Spilling the beans on the popular foods she avoided, Tami revealed she didn't consume complex carbs, such as spaghetti and toast. ''Pasta and bread made me feel quite sick, I learnt that during the way,'' she said in the video. ''White breads and white pasta I found that it was very much making me feel queasy, so I avoided that.'' Another item on the no-go list included red meat, as that gave her ''the sulphur burp'', which ''have a foul, rotten egg smell due to the presence of hydrogen sulfide gas'', as per Medical News Today. As well as being caused by gastrointestinal issues, sulphur burps can be a result of consuming too much legumes, dairy, poultry and other meat. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. ''I've now introduced it back into my diet but certainly in the beginning and when moving up doses,'' said Tami who's currently on 15mg of the medication. Another popular pick she steered clear of at the start of her weight loss journey was takeaway, especially ''fatty and greasy foods''. As well as making her stomach ''quite sick'', Tami discovered the greasy meals caused constipation - another common side effect of Mounjaro. ''Also, I would avoid anything high in sugar, sugary foods, like cakes.'' Offering a helping hand to those also on the medication, Tami advised to stay hydrated and ''eat your calories''. She went on in the video: ''I would say that if you've got any questions regarding foods or something's triggering you, write it down in a food diary. ''See what could made you feel sickly and probably take it out of your eating plan for that week and see if that's the trigger.'' What are the other side effects of weight loss jabs? Like any medication, weight loss jabs can have side effects. Common side effects of injections such as Ozempic include: Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts. Vomiting: Can occur, often in conjunction with nausea. Diarrhea: Some people experience gastrointestinal upset. Constipation: Some individuals may also experience constipation. Stomach pain or discomfort: Some people may experience abdominal pain or discomfort. Reduced appetite: This is often a desired effect for people using Ozempic for weight loss. Indigestion: Can cause a feeling of bloating or discomfort after eating. Serious side effects can also include: Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting. Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon. Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic. Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic. Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin. Other Mounjaro users react Since being posted on the platform, where Tami shares content under the username @cartcrushuk, the clip has taken the internet by storm, amassing over 368k views. More than 400 people flooded to comments, where many shared their experience with the fat jab. One person said: ''I am completely gone off chicken like makes me wanna vom.'' Someone else chimed in: ''Same I find highly processed carbs give me a bad belly I just stick to fresh protein and veg now lost 4 stone upto now.'' Another wrote: ''Week 8 …32lb side effects…I eat in deficient I drink 2.5 litres of water with electrolytes now gone up to 5mg loving it!'' The reality of Mounjaro Although many have boasted about weight loss success since using Mounjaro, last year it was revealed that Scots nurse Susan McGowan, 58, died after taking low-dose injections of Mounjaro over a fortnight. A probe also found that nearly 400 people have gone to hospital after taking weight loss drugs. The common side effects include nausea, vomiting and diarrhoea, which can lead to severe dehydration. And if that wasn't bad enough, doctors say they have also seen 'life-threatening complications', including seizures, bowel obstruction and inflammation of the pancreas. Model Lottie Moss, 27, even said she had a seizure after taking high doses of Ozempic. The makers of Mounjaro, Lilly UK, said patient safety is its 'top priority'. Lilly UK stressed: 'Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data. 'If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.'
